Idexx Laboratories, Inc. · NASDAQ:IDXX

Idexx Laboratories — Q4 2024 Earnings Presentation

5 slides from Idexx Laboratories's earnings presentation, Feb 3, 2025

  1. Slide 1: IDEXX Q4 & Full Year 2024 Earnings Highlights

    IDEXX Q4 & Full Year 2024 Earnings Highlights (NASDAQ: IDXX) Operating Diluted Revenue Profit Earnings Per Share Q4 $954M $262M $2.62 Reported growth: +6% 27% of Revenue Organic growth: +6% Reported growth: +13% YoY change in basis points: CAG Diagnostics Recurring Reported +20 Comparable growth: +1

  2. Slide 2: 2025 Growth and Financial Performance Outlook Commentary

    IDEXX Q4 & Full Year 2024 Earnings Highlights (NASDAQ: IDXX) 2025 Growth and Financial Performance Outlook Commentary • Provides initial outlook for 2025 revenue of $4,055 million - $4,170 million, reflecting reported revenue growth of 4% - 7% and organic growth of 6% - 9%, driven by 3% - 6% CAG Dia

  3. Slide 3: © 2025 IDEXX Laboratories, Inc. All rights reserved .

    © 2025 IDEXX Laboratories, Inc. All rights reserved. Contact: John Ravis, Investor Relations (207) 556-8155.

  4. Slide 4: © 2025 IDEXX Laboratories, Inc. All rights reserved .

    © 2025 IDEXX Laboratories, Inc. All rights reserved. Contact: John Ravis, Investor Relations (207) 556-8155.

  5. Slide 5: © 2025 IDEXX Laboratories, Inc. All rights reserved .

    © 2025 IDEXX Laboratories, Inc. All rights reserved. Contact: John Ravis, Investor Relations (207) 556-8155.

IDEXX Laboratories — Q4 2024 Earnings Presentation on 6ix